A ring-closing metathesis approach to cyclic α,β-dehydroamino acids

Advanced Synthesis and Catalysis

Volumn 350, Issue 1, 2008, Pages 95-106

  Hekking, Koen F W ^a   Waalboer, Dennis C J ^a   Moelands, Marcel A H ^a   Van Delft, Floris L ^a   Rutjes, Floris P J T ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

1,4 benzoquinone; Enamides; Isomerization; Nitrogen heterocycles; Olefin metathesis

Indexed keywords

EID: 38349183032     PISSN: 16154150     EISSN: 15213897     Source Type: Journal    
DOI: 10.1002/adsc.200700308     Document Type: Article

References (51)

1. a) C. H. Stammer, in: Chemistry and Biochemistry of Amino Acids, Peptides, and Proteins, (Ed.: B. Weinstein), Dekker, New York, 1982, p 33;
2. b) K. Nakamura, T. Isaka, A. Toshima, M. Kodaka, Tetrahedron Lett. 2004, 45, 7221 and references cited therein;
3. c) H. Zhou, W. A. van der Donk, Org. Lett. 2001, 3, 593 and references cited therein.
4. For reviews on the syntheses and reactions of dehydroamino acids, see: a) C. Bonauer, T. Walenzyk, B. König, Synthesis 2006, 1;
5. b) J. M. Humphrey, A. R. Chamberlin, Chem. Rev. 1997, 97, 2243;
6. c) U. Schmidt, A. Lieberknecht, J. Wild, Synthesis 1988, 159.
7. a) K. F. W. Hekking, M. A. H. Moelands, F. L. van Delft, F. P. J. T. Rutjes, J. Org. Chem. 2006, 71, 6444;
8. b) K. F. W. Hekking, F. L. van Delft, F. P. J. T. Rutjes, Tetrahedron 2003, 59, 6751.
9. S. S. Kinderman, J. H. van Maarseveen, H. E. Schoemaker, H. Hiemstra, F. P. J. T. Rutjes, Org. Lett. 2001, 3, 2045.
10. During the course of our investigations, two isolated examples of RCM of dehydroamino acid fragments were reported: a) L. Manzoni, M. Colombo, C. Scolastico, Tetrahedron Lett. 2004, 45, 2623;
11. b) J. D. Katz, L. E. Overman, Tetrahedron 2004, 60, 9559.
12. a) C. Kadouri-Puchot, S. Comesse, Amino Acids 2005, 29, 101;
13. b) L. A. Watanabe, S. Haranaka, B. Jose, M. Yoshida, T. Kato, M. Moriguchi, K. Soda, N. Nishino, Tetrahedron: Asymmetry 2005, 16, 903, and references cited therein.
14. a) L. R. Bush, Cardiovasc. Drug Revs. 1991, 9, 247;
15. b) S. Okamoto, K. Kinjo, A. Hijikata, J. Med. Chem. 1980, 23, 827;
16. c) S. Okamoto, Y. Funahara, A. Hijikata, J. Med. Chem. 1980, 23, 830;
17. d) S. Okamoto, A. Hijikata, J. Med. Chem. 1980, 23, 1293.
18. A. Hijikata-Okunomiya, Y. Tamao, R. Kikumoto, S. Okamotoi, J. Biol. Chem. 2000, 275, 18995.
19. a) D. Lamarre, G. Croteau, E. Wardrop, L. Bourgon, D. Thibeault, C. Clouette, M. Vaillancourt, E. Cohen, C. Pargellis, C. Yoakim, P. C. Anderson, Antimicrob. Agents Chemother. 1997, 41, 965;
20. b) P. L. Beaulieu, P. Lavalleé, A. Abraham, P. C. Anderson, C. Boucher, Y. Bousquet, J.-S. Duceppe, J. Gillard, V. Gorys, C. Grand-Maître, L. Grenier, Y. Guindon, I. Guse, L. Plamondon, F. Soucy, S. Valois, D. Wernic, C. Yoakim, J. Org. Chem. 1997, 62, 3440.
21. a) S. Rusconi, O. Viganò, Therapy 2006, 3, 79;
22. b) P. L. Beaulieu, P. C. Anderson, D. R. Cameron, G. Croteau, V. Gorys, C. Grand-Maitre, D. Lamarre, F. Liard, W. Paris, L. Plamondon, F. Soucy, D. Thibeault, D. Wernic, C. Yoakim, S. Pav, L. Tong, J. Med. Chem. 2000, 43, 1094.
23. J. E. Baldwin, A. C. Spivey, C. J. Schofield, J. B. Sweeney, Tetrahedron 1993, 49, 6309.
24. Y-F. Zhu, T. Yamazaki, J. W. Tsang, S. Lok, M. Goodman, J. Org. Chem. 1992, 57, 1074.
25. a) A. M. Warshawsky, G. A. Flynn, J. R. Koehl, S. Mehdi, R. J. Vaz, Bioorg. Med. Chem. Lett. 1996, 6, 957;
26. b) X. Fang, D. L. Larson, P. S. Portoghese, J. Med. Chem. 1997, 40, 3064.
27. G. Heuger, S. Kalsow, R. Göttlich, Eur. J. Org. Chem. 2002, 1848.
28. J. H. Cho, B. M. Kim, Org. Lett. 2003, 5, 531.
29. a) B. Schmidt, Eur. J. Org. Chem. 2004, 1865, and references cited therein;
30. b) J. C. Sworen, J. H. Pawlow, W. Case, J. Lever, K. B. Wagener, J. Mol. Catal. A: Chem. 2003, 194, 69;
31. c) A. E. Sutton, B. A. Seigal, D. F. Finnigan, M. L. Snapper, J. Am. Chem. Soc. 2002, 124, 13390;
32. d) C. Cadot, P. I. Dalko, J. Cossy, Tetrahedron Lett. 2002, 43, 1839.
33. M. T. Crimmins, Z. Wang, L. A. McKerlie, J. Am. Chem. Soc 1998, 8, 1747.
34. E. F. J. de Vries, J. Brussee, A. van der Gen, J. Org. Chem. 1994, 59, 7133.
35. The presence of a ruthenium hydride species has been suggested as a cause for olefin isomerization during RCM in a number of cases: a) S. H. Hong, M. H. Day, R. H. Grubbs, J. Am. Chem. Soc. 2004, 126, 7414;
36. b) J. Louie, R. H. Grubbs, Organometallics 2002, 21, 2153;
37. c) A. Fürstner, O. R. Thiel, L. Ackermann, H.-J. Schanz, S. P. Nolan, J. Org. Chem. 2000, 65, 2204.
38. For a recent screening to prevent isomerization in cross-metathesis, see: J. Moise, S. Arseniyadis, J. Cossy, Org. Lett. 2007, 9, 1695.
39. a) THF may coordinate to the metal center, thereby slowing down the catalysis as well as catalyst decomposition: C. W. Bielawski, O. A. Scherman, R. H. Grubbs, Polymer 2001, 42, 4939;
40. 3 is capable of halogen-hydride exchange: T. R. Belderrain, R. H. Grubbs, Organometallics 1997, 16, 4001.
41. a) D. Bourgeois, A. Pancrazi, S. P. Nolan, J. Prunet, J. Organomet. Chem. 2002, 643-644, 247;
42. b) P. Formentin, N. Gimeno, J. H. G. Steinke, R. Vilar, J. Org. Chem. 2005, 70, 8235.
43. 4 can coordinate to heteroatoms in substrates, preventing them from interfering with olefin metathesis and enhancing the rate and yield of cyclization: A. Fürstner, K. Langemann, J. Am. Chem. Soc. 1997, 119, 9130.
44. S. H. Hong, D. P. Sanders, C. W. Lee, R. H. Grubbs, J. Am. Chem. Soc 2005, 127, 17160.
45. K. F. W. Hekking, L. Lefort, A. H. M. de Vries, F. L. van Delft, H. E. Schoemaker, J. G. de Vries, F. P. J. T. Rutjes, Adv. Synth. Catal. preceding article in this issue.
46. L. De Luca, G. Giacomelli, A. Porcheddu, Org. Lett. 2001, 3, 3041.
47. D. Liotta, R. Monahan, J. Org. Chem. 1987, 19, 4191.
48. S. Y. Lee, Y. S. Kulkarni, B. W. Burbaum, M. I. Johnston, B. B. Snider, J. Org. Chem. 1988, 9, 1848.
49. M. Sannigrahi, D. L. Mayhew, D. L. J. Clive, J. Org. Chem. 1999, 64, 2776.
50. U. Jensen-Korte, H.-J. Schaefer, Liebigs Ann. Chem. 1982, 8, 1532.
51. N Kurose, T. Takahashi, T. Koizumi, J. Org. Chem. 1997, 62, 4562.